, Volume 169, Issue 2, pp 176–185

On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization

  • Louk J. M. J. Vanderschuren
  • Patricia Beemster
  • Anton N. M. Schoffelmeer
Original Investigation



Psychostimulant drugs exert their behavioral effects primarily through enhancement of monoaminergic neurotransmission. Augmented dopamine activity is thought to play a critical role in the psychomotor stimulant effects of amphetamine and cocaine, as well as in the development of long-term behavioral sensitization evoked by repeated exposure to amphetamine. However, despite the fact that brain dopamine and noradrenaline systems are closely interconnected, the extent to which noradrenergic transmission contributes to these behavioral effects of psychostimulants is a relatively unexplored issue.


By inhibiting noradrenergic neurotransmission with the α2-adrenoceptor agonist clonidine, the α1-antagonist prazosin and the β-antagonist propranolol, we investigated the involvement of noradrenaline neurotransmission in the psychomotor stimulant and long-term sensitizing effects of d-amphetamine and cocaine in rats.


Clonidine (0.003–0.1 mg/kg), prazosin (0.1–3.0 mg/kg) and propranolol (1.0–3.0 mg/kg) were administered prior to d-amphetamine (1.0 mg/kg), cocaine (15 mg/kg) or apomorphine (1.0 mg/kg) and psychomotor activity was measured. In separate studies, clonidine (0.03 mg/kg), prazosin (1.0 mg/kg) or propranolol (3.0 mg/kg) were co-administered with d-amphetamine (2.5 mg/kg) or cocaine (30 mg/kg) for 5 days, and locomotor sensitization was assessed 3 weeks post-treatment.


The psychomotor stimulant effect of d-amphetamine, but not that of cocaine or apomorphine, was dose-dependently inhibited by clonidine and prazosin, and enhanced by propranolol. Clonidine, prazosin, and propranolol did not influence the induction of sensitization by amphetamine or cocaine.


Enhancement of synaptic noradrenaline concentrations contributes to the psychomotor stimulant effect of d-amphetamine, but not cocaine or apomorphine. In addition, noradrenergic neurotransmission is not critically involved in the induction of psychostimulant sensitization.


Amphetamine Apomorphine Cocaine α-Adrenoceptors β-Adrenoceptors Locomotor activity Behavioral sensitization Clonidine Prazosin Propranolol 


  1. Aghajanian GK, VanderMaelen CP (1982) α2-Adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215:1394–1396PubMedGoogle Scholar
  2. Amalric M, Koob GF (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res 99:209–226PubMedGoogle Scholar
  3. Anagnostaras SG, Robinson TE (1996) Senzitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 110:1397–1414PubMedGoogle Scholar
  4. Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, Robinson TE (1998) Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18:10579–10593PubMedGoogle Scholar
  5. Berman DE, Dudai Y (2001) Memory extinction, learning anew, and learning the new: dissociations in the molecular machinery of learning in cortex. Science 291:2417–2419CrossRefPubMedGoogle Scholar
  6. Berthold CWI, Gonzales RA, Moerschbacher JM (1992) Prazosin attenuates the effects of cocaine on motor activity but not on schedule-controlled behavior in the rat. Pharmacol Biochem Behav 43:111–115CrossRefPubMedGoogle Scholar
  7. Bjijou Y, Stinus L, Le Moal M, Cador M (1996) Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of d-amphetamine. J Pharmacol Exp Ther 277:1177–1187PubMedGoogle Scholar
  8. Blanc G, Trovero F, Vezina P, Hervé D, Godeheu A-M, Glowinski J, Tassin JP (1994) Blockade of prefronto-cortical α1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical d-amphetamine injection. Eur J Neurosci 6:293–298PubMedGoogle Scholar
  9. Braszko JJ, Wisniewski K (1990) Alpha1 and alpha2-adrenergic receptor blockade influences angiotensin II facilitation of avoidance behavior and stereotypy in rats. Psychoneuroendocrinology 15:239–252CrossRefPubMedGoogle Scholar
  10. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385–395CrossRefPubMedGoogle Scholar
  11. Cahill L, Prins B, Weber M, McGaugh JL (1994) Beta-adrenergic activation and memory for emotional events. Nature 371:702–704PubMedGoogle Scholar
  12. Carey RJ, DePalma G, Damianopoulos E (2001) Cocaine and serotonin: a role for the 5-HT1A receptor site in the mediation of cocaine stimulant effects. Behav Brain Res 126:127–133CrossRefPubMedGoogle Scholar
  13. Castanon N, Scearce-Levie K, Lucas JJ, Rocha B, Hen R (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol Biochem Behav 67:559–566PubMedGoogle Scholar
  14. Cervo L, Bendotti C, Tarizzo G, Cagnotto A, Skorupska M, Mennini T, Samanin R (1994) Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors. Eur J Pharmacol 253:139–147CrossRefPubMedGoogle Scholar
  15. Cornish JL, Kalivas PW (2001) Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav Brain Res 126:205–209CrossRefPubMedGoogle Scholar
  16. Creese I, Iversen SD (1974) The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia 39:345–357Google Scholar
  17. Crombag HS, Badiani A, Maren S, Robinson TE (2000) The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine. Behav Brain Res 116:1–22CrossRefPubMedGoogle Scholar
  18. Crombag HS, Badiani A, Chan J, Dell'Orco J, Dineen SP, Robinson TE (2001) The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology 24:680–690CrossRefPubMedGoogle Scholar
  19. Darracq L, Blanc G, Glowinski J, Tassin JP (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine. J Neurosci 18:2729–2739PubMedGoogle Scholar
  20. De La Garza R II, Cunningham KA (2000) The effects of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292:610–617Google Scholar
  21. De Vries TJ, Schoffelmeer ANM, Binnekade R, Mulder AH, Vanderschuren LJMJ (1998) Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10:3565–3571PubMedGoogle Scholar
  22. Delfs JM, Schreiber L, Kelley AE (1990) Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303–310PubMedGoogle Scholar
  23. Deroche V, Le Moal M, Piazza PV (1999) Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur J Neurosci 11:2731–2736PubMedGoogle Scholar
  24. Dickinson SL, Gadie B, Tulloch IF (1988) α1- and α2-Adrenoceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology 96:521–527Google Scholar
  25. Drouin C, Blanc G, Villégier A-S, Glowinski J, Tassin JP (2002) Critical role of α1-adrenergic receptors in acute and sensitized locomotor effects of d-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51–61CrossRefPubMedGoogle Scholar
  26. Filip M, Nowak E, Papla I (2001) On the role of serotonin2A/2C receptors in the sensitization to cocaine. J Physiol Pharmacol 52:471–481PubMedGoogle Scholar
  27. Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753PubMedGoogle Scholar
  28. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79–84CrossRefPubMedGoogle Scholar
  29. Harris GC, Hedaya MA, Pan W-J, Kalivas P (1996) β-Adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology 14:195–204CrossRefPubMedGoogle Scholar
  30. Hoyer D, Engel G, Kalkman HO (1985) Characterization of the 5-HT1B recognition site in rat brain: binding studies with (−)[125I]iodocyanopindolol. Eur J Pharmacol 118:1–12CrossRefPubMedGoogle Scholar
  31. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979–1986PubMedGoogle Scholar
  32. Kalivas PW, Weber B (1988) Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095–1102PubMedGoogle Scholar
  33. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522PubMedGoogle Scholar
  34. Kuczenski R, Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051–2065PubMedGoogle Scholar
  35. Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712PubMedGoogle Scholar
  36. Kuczenski R, Segal DS, Cho AK, Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308–1317PubMedGoogle Scholar
  37. Kuczenski R, Segal DS, Todd PK (1997) Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134:221–229CrossRefPubMedGoogle Scholar
  38. Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155–234PubMedGoogle Scholar
  39. Li Y, Wolf ME (1999) Can the "state-dependency" hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists? Psychopharmacology 141:351–361Google Scholar
  40. Mattingly BA, Hart TC, Lim K, Perkins C (1994) Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology 114:239–242PubMedGoogle Scholar
  41. Nicola SM, Malenka RC (1998) Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. J Neurophysiol 79:1768–1776PubMedGoogle Scholar
  42. Nomikos G, Damsma G, Wenkstern D, Fibiger HC (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106–112PubMedGoogle Scholar
  43. Nurse B, Russell VA, Taljaard JJ (1984) α2 and β-Adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: implications for research into depression. Neurochem Res 9:1231–1238PubMedGoogle Scholar
  44. Oksenberg D, Peroutka SJ (1988) Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Biochem Pharmacol 37:3429–3433PubMedGoogle Scholar
  45. Paladini CA, Fiorillo CD, Morikawa H, Williams JT (2001) Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nature Neurosci 4:275–281CrossRefGoogle Scholar
  46. Perugini M, Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690–696PubMedGoogle Scholar
  47. Przegalinski E, Filip M (1997) Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav Pharmacol 8:699–706PubMedGoogle Scholar
  48. Przegalinski E, Siwanowicz J, Nowak E, Papla I, Filip M (2001) Role of 5-HT1B receptors in the sensitization to amphetamine in mice. Eur J Pharmacol 422:91–99PubMedGoogle Scholar
  49. Przybyslawski J, Roullet P, Sara SJ (2001) Attenuation of emotional and nonemotional memories after their reactivation: role of β-adrenergic receptors. J Neurosci 19:6623–6628Google Scholar
  50. Reith MEA, Li M-Y, Yan Q-S (1997) Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134:309–317CrossRefPubMedGoogle Scholar
  51. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010–1017PubMedGoogle Scholar
  52. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247–291PubMedGoogle Scholar
  53. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 [Suppl 2]:S91–S117Google Scholar
  54. Robinson TE, Browman KE, Crombag HS, Badiani A (1998) Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev 22:347–354PubMedGoogle Scholar
  55. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41PubMedGoogle Scholar
  56. Sahakian BJ, Robbins TW, Morgan MJ, Iversen SD (1975) The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats. Brain Res 84:195–205PubMedGoogle Scholar
  57. Schoffelmeer ANM, Mulder AH (1984) Presynaptic opiate receptor- and α2-adrenoceptor-mediated inhibition of noradrenaline release in the rat brain: role of hyperpolarization? Eur J Pharmacol 105:129–135Google Scholar
  58. Schoffelmeer ANM, De Vries TJ, Wardeh G, van de Ven HWM, Vanderschuren LJMJ (2002) Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22:3269–3276PubMedGoogle Scholar
  59. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639–677CrossRefGoogle Scholar
  60. Shi W-X, Pun C-L, Zhang X-X, Jones MD, Bunney BS (2000) Dual effects of d-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J Neurosci 20:3504–3511PubMedGoogle Scholar
  61. Snoddy AM, Tessel RE (1985) Prazosin: effect on psychomotor stimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221–228PubMedGoogle Scholar
  62. Stewart J, Vezina P (1989) Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495:401–406PubMedGoogle Scholar
  63. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102–4108Google Scholar
  64. Suyama K, Dykstra KH, Masana MI, Manji HK, Potter WZ (1994) In vivo evidence that nonneuronal β-adrenoceptors as well as dopamine receptors contribute to cyclic AMP efflux in rat striatum. J Neurochem 62:1734–1740PubMedGoogle Scholar
  65. Thiébot M-H, Kloczko J, Chermat R, Puech AJ, Soubrié P, Simon P (1981) Enhancement of cocaine-induced hyperactivity in mice by benzodiazepines: evidence for an interaction of GABAergic processes with catecholaminergic neurons? Eur J Pharmacol 76:335–343Google Scholar
  66. Uslaner J, Badiani A, Norton CS, Day HEW, Watson SJ, Akil H, Robinson TE (2001) Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13:1977–1983CrossRefPubMedGoogle Scholar
  67. Vanderschuren LJMJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99–120PubMedGoogle Scholar
  68. Vanderschuren LJMJ, Wardeh G, De Vries TJ, Mulder AH, Schoffelmeer ANM (1999) Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. J Neurosci 19:4123–4131PubMedGoogle Scholar
  69. Vanderschuren LJMJ, Schoffelmeer ANM, Wardeh G, De Vries TJ (2000) Dissociable effects of the k-opioid receptor agonists bremazocine, U69593 and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine. Psychopharmacology 150:35–44CrossRefPubMedGoogle Scholar
  70. Vezina P (1996) D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16:2411–2420PubMedGoogle Scholar
  71. Wellman P, Ho D, Cepeda-Benito A, Bellinger L, Nation J (2002) Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by prazosin. Eur J Pharmacol 455:117–126CrossRefPubMedGoogle Scholar
  72. Westerink BHC, Tuntler J, Damsma G, Rollema H, De Vries JB (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch Pharmacol 336:502–507Google Scholar
  73. White FJ, Joshi A, Koeltzow TE, Hu X-T (1998) Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26–40Google Scholar
  74. Wolf ME, Dahlin SL, Hu X-T, Xue C-J, White K (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-d-aspartate antagonists. Neuroscience 69:417–439PubMedGoogle Scholar
  75. Yavich L, Lappalainen R, Sirviö J, Haapalinna A, MacDonald E (1997) α2-Adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur J Pharmacol 339:113–119CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Louk J. M. J. Vanderschuren
    • 1
  • Patricia Beemster
    • 1
  • Anton N. M. Schoffelmeer
    • 1
  1. 1.Drug Abuse Program, Department of Medical Pharmacology, Research Institute Neurosciences VUVU Medical CenterAmsterdamThe Netherlands

Personalised recommendations